Oct 08, 2020 10:14am EDT XORTX Receives Positive Feedback from FDA on COVID-19 Related Acute Kidney Injury
Sep 15, 2020 7:00am EDT XORTX Highlights New Studies of Acute Kidney Disease Due to COVID-19 Infection
Aug 31, 2020 7:00am EDT XORTX Files U.S. FDA Pre-IND Meeting Request for XRx-101 (Oxypurinol) COVID-19 Program and Pre-IND Meeting Submission
Aug 04, 2020 10:11am EDT XORTX Partners with Mount Sinai’s Icahn School of Medicine on US-based Clinical Trial in COVID-19